Conflicting forces of warfarin and matrix gla protein in the artery wall.
作者信息
Demer Linda L, Boström Kristina I
机构信息
From the Division of Cardiology, Department of Medicine (L.L.D., K.I.B.) and Departments of Physiology and Bioengineering, University of California at Los Angeles (L.L.D.).
出版信息
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):9-10. doi: 10.1161/ATVBAHA.114.304793.
Abstract
摘要
相似文献
1
Conflicting forces of warfarin and matrix gla protein in the artery wall.华法林与动脉壁中基质γ-羧基谷氨酸蛋白之间的相互冲突作用。
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):9-10. doi: 10.1161/ATVBAHA.114.304793.
2
Increased vascular calcification in patients receiving warfarin.接受华法林治疗的患者血管钙化增加。
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):237-42. doi: 10.1161/ATVBAHA.114.304392. Epub 2014 Oct 16.
3
Warfarin and Vascular Calcification.华法林与血管钙化
Am J Med. 2016 Jun;129(6):635.e1-4. doi: 10.1016/j.amjmed.2015.11.032. Epub 2015 Dec 20.
4
Research progress of warfarin-associated vascular calcification and its possible therapy.华法林相关性血管钙化及其可能的治疗方法的研究进展。
J Cardiovasc Pharmacol. 2014 Jan;63(1):76-82. doi: 10.1097/FJC.0000000000000008.
5
The Effects of Warfarin and Direct Oral Anticoagulants on Systemic Vascular Calcification: A Review.华法林和直接口服抗凝剂对全身血管钙化的影响：综述。
Cells. 2021 Mar 31;10(4):773. doi: 10.3390/cells10040773.
6
Increased Peripheral Arterial Calcification in Patients Receiving Warfarin.接受华法林治疗的患者外周动脉钙化增加。
J Am Heart Assoc. 2016 Jan 25;5(1):e002665. doi: 10.1161/JAHA.115.002665.
7
Warfarin accelerated vascular calcification and worsened cardiac dysfunction in remnant kidney mice.华法林加速了残余肾脏小鼠的血管钙化并加重了心脏功能障碍。
J Chin Med Assoc. 2018 Apr;81(4):324-330. doi: 10.1016/j.jcma.2017.08.021. Epub 2018 Feb 13.
8
Warfarin Use Is Associated With Progressive Coronary Arterial Calcification: Insights From Serial Intravascular Ultrasound.华法林的使用与冠状动脉钙化的进展有关：来自连续血管内超声的见解。
JACC Cardiovasc Imaging. 2018 Sep;11(9):1315-1323. doi: 10.1016/j.jcmg.2017.04.010. Epub 2017 Jul 19.
9
Prothrombin Loading of Vascular Smooth Muscle Cell-Derived Exosomes Regulates Coagulation and Calcification.血管平滑肌细胞衍生外泌体的凝血酶原负载调节凝血和钙化。
Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):e22-e32. doi: 10.1161/ATVBAHA.116.308886. Epub 2017 Jan 19.
10
Warfarin Accelerates Medial Arterial Calcification in Humans.华法林加速人类的动脉中层钙化。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1413-1419. doi: 10.1161/ATVBAHA.119.313879. Epub 2020 Feb 13.
引用本文的文献
1
Revealing the mechanisms of warfarin-induced vascular calcification through metabolomics and network toxicology.通过代谢组学和网络毒理学揭示华法林诱导血管钙化的机制。
Front Pharmacol. 2025 Jun 9;16:1554987. doi: 10.3389/fphar.2025.1554987. eCollection 2025.
2
Coumarins in Anticancer Therapy: Mechanisms of Action, Potential Applications and Research Perspectives.香豆素类在抗癌治疗中的作用机制、潜在应用及研究展望
Pharmaceutics. 2025 May 1;17(5):595. doi: 10.3390/pharmaceutics17050595.
3
The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review.他汀类药物对血管钙化的复杂机制及潜在影响：一项叙述性综述
Rev Cardiovasc Med. 2024 Jan 30;25(2):51. doi: 10.31083/j.rcm2502051. eCollection 2024 Feb.
4
Mechanisms of Cardiovascular Calcification and Experimental Models: Impact of Vitamin K Antagonists.心血管钙化的机制及实验模型：维生素K拮抗剂的影响
J Clin Med. 2024 Feb 29;13(5):1405. doi: 10.3390/jcm13051405.
5
Effects of Eicosapentaenoic Acid on Arterial Calcification.二十碳五烯酸对动脉钙化的影响。
Int J Mol Sci. 2020 Jul 30;21(15):5455. doi: 10.3390/ijms21155455.
6
Vitamin K Status, Warfarin Use, and Arterial Stiffness in Heart Failure.维生素 K 状态、华法林使用与心力衰竭患者的动脉僵硬度。
Hypertension. 2019 Feb;73(2):364-370. doi: 10.1161/HYPERTENSIONAHA.118.12157.
7
Where do we stand on vascular calcification?我们对血管钙化的研究进展如何？
Vascul Pharmacol. 2016 Sep;84:8-14. doi: 10.1016/j.vph.2016.05.014. Epub 2016 May 31.
8
Bidirectional Translation in Cardiovascular Calcification.心血管钙化中的双向翻译。
Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):e19-24. doi: 10.1161/ATVBAHA.115.307056.
本文引用的文献
1
Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.遗传性出血性毛细血管扩张症1型和2型动物模型中动静脉畸形的共同和独特发病机制特征——简要报告
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2232-6. doi: 10.1161/ATVBAHA.114.303984. Epub 2014 Jul 31.
2
The role of BMPs in endothelial cell function and dysfunction.BMPs 在血管内皮细胞功能和功能障碍中的作用。
Trends Endocrinol Metab. 2014 Sep;25(9):472-80. doi: 10.1016/j.tem.2014.05.003. Epub 2014 Jun 4.
3
Genetic risk factors for major bleeding in patients treated with warfarin in a community setting.社区环境中使用华法林治疗的患者发生大出血的遗传风险因素。
Clin Pharmacol Ther. 2014 Jun;95(6):636-43. doi: 10.1038/clpt.2014.26. Epub 2014 Feb 6.
4
Reducing Jagged 1 and 2 levels prevents cerebral arteriovenous malformations in matrix Gla protein deficiency.降低 Jagged1 和 Jagged2 水平可预防基质 Gla 蛋白缺乏症的脑动静脉畸形。
Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19071-6. doi: 10.1073/pnas.1310905110. Epub 2013 Nov 4.
5
Matrix Gla protein reinforces angiogenic resolution.基质 Gla 蛋白增强血管生成的分辨率。
Microvasc Res. 2013 Jan;85:24-33. doi: 10.1016/j.mvr.2012.10.005. Epub 2012 Oct 27.
6
Matrix GLA protein, an inhibitory morphogen in pulmonary vascular development.基质γ-羧基谷氨酸蛋白，一种肺血管发育中的抑制性形态发生素。
J Biol Chem. 2007 Oct 12;282(41):30131-42. doi: 10.1074/jbc.M704297200. Epub 2007 Aug 1.
7
Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification.新型抗基质γ-羧基谷氨酸（Gla）蛋白构象特异性抗体：未羧化基质Gla蛋白作为血管钙化的标志物
Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1629-33. doi: 10.1161/01.ATV.0000173313.46222.43. Epub 2005 Jun 16.
8
Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells.基质γ-羧基谷氨酸蛋白调节骨形态发生蛋白-2在C3H10T1/2细胞中诱导的分化。
J Biol Chem. 2001 Apr 27;276(17):14044-52. doi: 10.1074/jbc.M008103200. Epub 2001 Jan 26.
9
Warfarin-induced artery calcification is accelerated by growth and vitamin D.华法林诱导的动脉钙化会因生长和维生素D而加速。
Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):317-27. doi: 10.1161/01.atv.20.2.317.
Zotero 插件